Metastatic Breast Cancer With HER2 Positive
Also known as: HER2-positive, Metastatic Breast Cancer / Metastatic HER2/Neu-positive Breast Cancer / HER2 Positive Metastatic Breast Cancers / Metastatic HER2-Positive Breast Cancer / Her2 Positive Metastatic Breast Cancer / Breast Cancer; HER2-positive; Metastatic / HER2-positive Metastatic Breast Cancer / HER-2 Positive Metastatic Breast Cancer / Metastasis from human epidermal growth factor 2 positive carcinoma of breast (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB14967 | Margetuximab | An Fc-engineered human/mouse chimeric IgG1κ anti-HER2 monoclonal antibody indicated for patients with HER2-positive metastatic breast cancer. |
DB14962 | Trastuzumab deruxtecan | An antibody used to treat certain types of unresectable or metastatic HER2 positive breast cancer. |
DB05773 | Trastuzumab emtansine | An antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer. |